Short description
Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Description
Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.
They have built a pipeline backed by a discovery engine with an extensive library of proprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Daix, Bourgogne, France, Europe
Founded on
January 1, 2011
Exited on
July 10, 2020
Went public on
July 10, 2020
Stock symbol
IVA
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noaccessforu, Noaccess, Uh Ohhhh, Blurry Noaccess, Nopepepe, Cannot Access, Noaccess, Noaccessforu, No Way, Noaccess
Sign in for full access
Founders
Frederic Cren, Pierre Broqua